Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan 13;12(2):ofaf018.
doi: 10.1093/ofid/ofaf018. eCollection 2025 Feb.

Pulmonary Coinfection of Pneumocystis jirovecii and Aspergillus Species

Affiliations

Pulmonary Coinfection of Pneumocystis jirovecii and Aspergillus Species

Stefan Hatzl et al. Open Forum Infect Dis. .

Erratum in

Abstract

In this multicenter study of 387 patients who were immunocompromised, 4.5% with invasive pulmonary aspergillosis also had Pneumocystis jirovecii pneumonia. Predictors of coinfection included elevated β-D-glucan and prolonged corticosteroid use. Coinfection correlated with reduced 30-day survival (22% vs 57%), suggesting that early identification and prophylaxis may improve outcomes.

Keywords: PCP-IPA coinfection; Pneumocystis jirovecii; aspergillosis; immunocompromised patients; invasive pulmonary aspergillosis.

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. M. H. received research funding from Gilead, Astellas, MSD, IMMY, Pulmocide, Shionogi, Melinta, Mundipharma, Scynexis, F2G, and Pfizer, all unrelated to the submitted work. R. K. received research grants from Merck and Pfizer, both unrelated to the submitted work. All other authors report no potential conflicts.

Figures

Graphical abstract
Graphical abstract
Figure 1.
Figure 1.
Survival analysis of patients with IPA-PCP coinfection. A, Kaplan-Meier plot comparing survival rates of patients with IPA-PCP coinfection with those with IPA alone. B, Results from the multivariable Cox regression model in a forest plot for enhanced readability. Abbreviations: APACHE II, Acute Physiology and Chronic Health Evaluation II; Asp, aspergillus; GM, galactomannan; IPA, invasive pulmonary aspergillosis; PCP, Pneumocystis pneumonia.

References

    1. McDonald EG, Butler-Laporte G, Del Corpo O, et al. On the treatment of Pneumocystis jirovecii pneumonia: current practice based on outdated evidence. Open Forum Infect Dis 2021; 8:ofab545. - PMC - PubMed
    1. Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group education and research consortium. Clin Infect Dis 2020; 71:1367–76. - PMC - PubMed
    1. Markantonatou A, Ioakimidou A, Arvaniti K, et al. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: a report of two cases and literature review. Mycoses 2017; 60:626–33. - PubMed
    1. Bassetti M, Giacobbe DR, Agvald-Ohman C, et al. Invasive fungal diseases in adult patients in intensive care unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM. Intensive Care Med 2024; 50: 502–15. - PMC - PubMed
    1. Hatzl S, Posch F, Linhofer M, et al. Poor prognosis for Puumala virus infections predicted by lymphopenia and dyspnea. Emerg Infect Dis 2023; 29:1038–41. - PMC - PubMed